Literature DB >> 13343058

Mestinon (pyridostigmine bromide) in myasthenia gravis.

H SCHWARZ.   

Abstract

Entities:  

Keywords:  CURARE/antagonists; MYASTHENIA GRAVIS/therapy; PARASYMPATHOMIMETICS/therapeutic use

Mesh：

Substances：

Year:  1956        PMID： 13343058      PMCID： PMC1824124     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  3 in total

1.  Treatment of myasthenia gravis with mestinon bromide.

Authors:  J E TETHER
Journal:  J Am Med Assoc       Date:  1956-01-21

2.  [Chemotherapy of myasthenia].

Authors:  H BAUER; O SCHMID
Journal:  Dtsch Z Nervenheilkd       Date:  1953

3.  Parasympathomimetic symptoms, sensitivity to acetylcholine and decurarization, in relation to inhibition of cholinesterases.

Authors:  H CASIER; R VERBEKE
Journal:  Arch Int Pharmacodyn Ther       Date:  1950-08-01
  3 in total
  1 in total

1.  Current and emerging treatments for the management of myasthenia gravis.

Authors:  Sivakumar Sathasivam
Journal:  Ther Clin Risk Manag       Date:  2011-07-22       Impact factor: 2.423
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.